NCT00311883View on ClinicalTrials.gov

Hydroxychloroquine in Cystic Fibrosis

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Cystic Fibrosis
Interventions
DRUG

hydroxychloroquine

Trial Locations (1)

37232

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
lead

Vanderbilt University

OTHER

NCT00311883 - Hydroxychloroquine in Cystic Fibrosis | Biotech Hunter | Biotech Hunter